Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Atp10d | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATP10D mRNA | CTD | PMID:22079256 | Atp10d | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of ATP10D mRNA | CTD | PMID:22206623 | Atp10d | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ATP10D mRNA | CTD | PMID:17557909 | Atp10d | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Atp10d (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP10D mRNA | CTD | PMID:21570461 | Atp10d | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ATP10D mRNA | CTD | PMID:34747641 | Atp10d | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of ATP10D mRNA | CTD | PMID:30851411 | Atp10d | Rat | 2-palmitoylglycerol | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ATP10D mRNA | CTD | PMID:37199045 | Atp10d | Rat | aflatoxin B1 | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of ATP10D mRNA | CTD | PMID:19770486 | Atp10d | Rat | aflatoxin B1 | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of ATP10D mRNA | CTD | PMID:27153756 | Atp10d | Rat | all-trans-retinoic acid | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ATP10D mRNA | CTD | PMID:21934132 and PMID:33167477 | Atp10d | Rat | benzo[a]pyrene | increases mutagenesis | ISO | ATP10D (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of ATP10D gene | CTD | PMID:25435355 | Atp10d | Rat | benzo[a]pyrene | affects methylation | ISO | ATP10D (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ATP10D 5' UTR | CTD | PMID:27901495 | Atp10d | Rat | benzo[a]pyrene | increases methylation | ISO | Atp10d (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of ATP10D intron | CTD | PMID:27901495 | Atp10d | Rat | benzo[a]pyrene | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ATP10D mRNA | CTD | PMID:22228805 and PMID:27195522 | Atp10d | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ATP10D mRNA | CTD | PMID:25181051 | Atp10d | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ATP10D mRNA | CTD | PMID:34947998 | Atp10d | Rat | bisphenol A | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | bisphenol A results in increased expression of ATP10D mRNA | CTD | PMID:25594700 | Atp10d | Rat | cadmium atom | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP10D mRNA | CTD | PMID:35301059 | Atp10d | Rat | cadmium dichloride | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP10D mRNA | CTD | PMID:35301059 | Atp10d | Rat | choline | multiple interactions | ISO | Atp10d (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP10D mRNA | CTD | PMID:20938992 | Atp10d | Rat | chromium(6+) | decreases expression | ISO | ATP10D (Homo sapiens) | 6480464 | chromium hexavalent ion results in decreased expression of ATP10D mRNA | CTD | PMID:30690063 | Atp10d | Rat | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ATP10D mRNA | CTD | PMID:22023808 | Atp10d | Rat | cyclosporin A | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ATP10D mRNA | CTD | PMID:20106945 | Atp10d | Rat | cyclosporin A | decreases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ATP10D mRNA | CTD | PMID:25562108 and PMID:27989131 | Atp10d | Rat | cytarabine | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Cytarabine results in increased expression of ATP10D mRNA | CTD | PMID:19194470 | Atp10d | Rat | dichloroacetic acid | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of ATP10D mRNA | CTD | PMID:28962523 | Atp10d | Rat | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of ATP10D mRNA | CTD | PMID:17005392 | Atp10d | Rat | dimethylarsinic acid | multiple interactions | ISO | Atp10d (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP10D mRNA | CTD | PMID:34876320 | Atp10d | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of ATP10D mRNA | CTD | PMID:21551480 | Atp10d | Rat | dorsomorphin | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Atp10d | Rat | doxorubicin | decreases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ATP10D mRNA | CTD | PMID:29803840 | Atp10d | Rat | elemental selenium | decreases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Selenium results in decreased expression of ATP10D mRNA | CTD | PMID:19244175 | Atp10d | Rat | entinostat | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | entinostat results in increased expression of ATP10D mRNA | CTD | PMID:27188386 | Atp10d | Rat | folic acid | multiple interactions | ISO | Atp10d (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP10D mRNA | CTD | PMID:20938992 | Atp10d | Rat | FR900359 | increases phosphorylation | ISO | ATP10D (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of ATP10D protein | CTD | PMID:37730182 | Atp10d | Rat | isoprenaline | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | Isoproterenol results in increased expression of ATP10D mRNA | CTD | PMID:20003209 | Atp10d | Rat | L-methionine | multiple interactions | ISO | Atp10d (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP10D mRNA | CTD | PMID:20938992 | Atp10d | Rat | mercury dibromide | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of ATP10D mRNA | CTD | PMID:26272509 | Atp10d | Rat | mercury dibromide | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP10D mRNA | CTD | PMID:27188386 | Atp10d | Rat | methylarsonic acid | multiple interactions | ISO | Atp10d (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP10D mRNA | CTD | PMID:34876320 | Atp10d | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of ATP10D mRNA | CTD | PMID:25380136 | Atp10d | Rat | paracetamol | affects expression | ISO | Atp10d (Mus musculus) | 6480464 | Acetaminophen affects the expression of ATP10D mRNA | CTD | PMID:17562736 | Atp10d | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ATP10D mRNA | CTD | PMID:33387578 | Atp10d | Rat | paracetamol | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ATP10D mRNA | CTD | PMID:22230336 and PMID:29067470 | Atp10d | Rat | phenethyl isothiocyanate | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | phenethyl isothiocyanate results in increased expression of ATP10D mRNA | CTD | PMID:26678675 | Atp10d | Rat | phenylmercury acetate | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of ATP10D mRNA | CTD | PMID:26272509 | Atp10d | Rat | phenylmercury acetate | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP10D mRNA | CTD | PMID:27188386 | Atp10d | Rat | pirinixic acid | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ATP10D mRNA | CTD | PMID:18301758 more ... | Atp10d | Rat | potassium chromate | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATP10D mRNA | CTD | PMID:22079256 | Atp10d | Rat | potassium chromate | decreases expression | ISO | ATP10D (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of ATP10D mRNA | CTD | PMID:22079256 and PMID:22714537 | Atp10d | Rat | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of ATP10D mRNA | CTD | PMID:28903501 | Atp10d | Rat | rac-lactic acid | decreases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of ATP10D mRNA | CTD | PMID:30851411 | Atp10d | Rat | rotenone | decreases expression | ISO | Atp10d (Mus musculus) | 6480464 | Rotenone results in decreased expression of ATP10D mRNA | CTD | PMID:32937126 | Atp10d | Rat | SB 431542 | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Atp10d | Rat | selenium atom | decreases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Selenium results in decreased expression of ATP10D mRNA | CTD | PMID:19244175 | Atp10d | Rat | silicon dioxide | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of ATP10D mRNA | CTD | PMID:23221170 | Atp10d | Rat | silver atom | decreases expression | ISO | Atp10d (Mus musculus) | 6480464 | Silver results in decreased expression of ATP10D mRNA | CTD | PMID:27131904 | Atp10d | Rat | silver(0) | decreases expression | ISO | Atp10d (Mus musculus) | 6480464 | Silver results in decreased expression of ATP10D mRNA | CTD | PMID:27131904 | Atp10d | Rat | sodium arsenate | multiple interactions | ISO | Atp10d (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP10D mRNA | CTD | PMID:34876320 | Atp10d | Rat | sodium arsenite | multiple interactions | ISO | Atp10d (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP10D mRNA | CTD | PMID:34876320 | Atp10d | Rat | sotorasib | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ATP10D mRNA | CTD | PMID:36139627 | Atp10d | Rat | Tesaglitazar | increases expression | EXP | | 6480464 | tesaglitazar results in increased expression of ATP10D mRNA | CTD | PMID:21515302 | Atp10d | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ATP10D mRNA | CTD | PMID:34492290 | Atp10d | Rat | titanium dioxide | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | titanium dioxide results in increased expression of ATP10D mRNA | CTD | PMID:23557971 | Atp10d | Rat | titanium dioxide | decreases expression | ISO | Atp10d (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ATP10D mRNA | CTD | PMID:29264374 | Atp10d | Rat | trametinib | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ATP10D mRNA | CTD | PMID:36139627 | Atp10d | Rat | trichloroethene | increases expression | ISO | Atp10d (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of ATP10D mRNA | CTD | PMID:25549359 | Atp10d | Rat | trichostatin A | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ATP10D mRNA | CTD | PMID:24935251 | Atp10d | Rat | urethane | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Urethane results in increased expression of ATP10D mRNA | CTD | PMID:28818685 | Atp10d | Rat | valproic acid | affects expression | ISO | Atp10d (Mus musculus) | 6480464 | Valproic Acid affects the expression of ATP10D mRNA | CTD | PMID:17292431 | Atp10d | Rat | valproic acid | affects expression | ISO | ATP10D (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ATP10D mRNA | CTD | PMID:25979313 | Atp10d | Rat | valproic acid | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ATP10D mRNA | CTD | PMID:23179753 more ... | Atp10d | Rat | valproic acid | multiple interactions | ISO | ATP10D (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP10D mRNA | CTD | PMID:27188386 | Atp10d | Rat | vorinostat | increases expression | ISO | ATP10D (Homo sapiens) | 6480464 | vorinostat results in increased expression of ATP10D mRNA | CTD | PMID:27188386 | |